122 related articles for article (PubMed ID: 27393718)
1. A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?
Postlewait LM; Baptiste GG; Ethun CG; Le N; Cardona K; Russell MC; Willingham FF; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Oct; 114(5):576-580. PubMed ID: 27393718
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.
Postlewait LM; Ethun CG; Baptiste GG; Le N; McInnis MR; Cardona K; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Sep; 114(4):440-5. PubMed ID: 27334541
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: A Digestive Endoscopy Society of Tawian (DEST).
Chung CS; Tsai CL; Chu YY; Chen KC; Lin JC; Chen BC; Sun WC; Yen HH; Chen CY; Wu IC; Kuo CH; Shih HY; Bair MJ; Wang JP; Hu WH; Yang CS; Han ML; Cheng TY; Tseng CM; Tsai MC; Hu ML; Wang HP
Medicine (Baltimore); 2018 Sep; 97(38):e12101. PubMed ID: 30235663
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years.
Baptiste GG; Postlewait LM; Ethun CG; Le N; McInnis MR; Russell MC; Winer JH; Kooby DA; Staley CA; Maithel SK; Cardona K
J Surg Oncol; 2016 Aug; 114(2):163-9. PubMed ID: 27157897
[TBL] [Abstract][Full Text] [Related]
5. Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.
Chen WC; Warner RR; Ward SC; Harpaz N; Divino CM; Itzkowitz SH; Kim MK
Dig Dis Sci; 2015 Apr; 60(4):996-1003. PubMed ID: 25399327
[TBL] [Abstract][Full Text] [Related]
6. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.
Tsolakis AV; Ragkousi A; Vujasinovic M; Kaltsas G; Daskalakis K
World J Gastroenterol; 2019 Sep; 25(35):5376-5387. PubMed ID: 31558880
[TBL] [Abstract][Full Text] [Related]
7. Surgical indication of type I gastric neuroendocrine tumors.
Ruiz Pardo J; Sánchez Fuentes PA; Vidaña Márquez E; García-Redondo M; González Sánchez D; Belda Lozano R; Ferrer-Márquez M; Reina Duarte Á
Rev Esp Enferm Dig; 2024 May; 116(5):280-282. PubMed ID: 37170558
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors.
Uygun A; Kadayifci A; Polat Z; Yilmaz K; Gunal A; Demir H; Bagci S
J Surg Oncol; 2014 Feb; 109(2):71-4. PubMed ID: 24165913
[TBL] [Abstract][Full Text] [Related]
9. Gastric Neuroendocrine Tumors: Reappraisal of Type in Predicting Outcome.
Hanna A; Kim-Kiselak C; Tang R; Metz DC; Yang Z; DeMatteo R; Fraker DL; Roses RE
Ann Surg Oncol; 2021 Dec; 28(13):8838-8846. PubMed ID: 34120268
[TBL] [Abstract][Full Text] [Related]
10. Defining prognostic parameters of well-differentiated gastric neuroendocrine tumors based on metastatic potential: a two-center experience.
Kurtulan O; Turhan N; Gedikoğlu G; Akyol A; Sökmensüer C
Acta Gastroenterol Belg; 2022; 85(2):339-345. PubMed ID: 35709778
[TBL] [Abstract][Full Text] [Related]
11. Recurrent gastric neuroendocrine tumors treated with total gastrectomy.
Jung M; Kim JW; Jang JY; Chang YW; Park SH; Kim YH; Kim YW
World J Gastroenterol; 2015 Dec; 21(46):13195-200. PubMed ID: 26675502
[TBL] [Abstract][Full Text] [Related]
12. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
[TBL] [Abstract][Full Text] [Related]
13. Small bowel neuroendocrine tumors: A critical analysis of diagnostic work-up and operative approach.
Ethun CG; Postlewait LM; Baptiste GG; McInnis MR; Cardona K; Russell MC; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Nov; 114(6):671-676. PubMed ID: 27511436
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment and prognosis of gastric neuroendocrine neoplasms: a single-center experience.
Shen C; Chen H; Chen H; Yin Y; Han L; Chen J; Tang S; Yin X; Zhou Z; Zhang B; Chen Z
BMC Gastroenterol; 2016 Sep; 16(1):111. PubMed ID: 27613657
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
Vanoli A; La Rosa S; Miceli E; Klersy C; Maragliano R; Capuano F; Persichella A; Martino M; Inzani F; Luinetti O; Di Sabatino A; Sessa F; Paulli M; Corazza GR; Rindi G; Bordi C; Capella C; Solcia E
Neuroendocrinology; 2018; 107(2):114-126. PubMed ID: 29895024
[TBL] [Abstract][Full Text] [Related]
16. Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment.
Schindl M; Kaserer K; Niederle B
Arch Surg; 2001 Jan; 136(1):49-54. PubMed ID: 11146777
[TBL] [Abstract][Full Text] [Related]
17. Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses.
Kim BS; Oh ST; Yook JH; Kim KC; Kim MG; Jeong JW; Kim BS
Am J Surg; 2010 Sep; 200(3):328-33. PubMed ID: 20385369
[TBL] [Abstract][Full Text] [Related]
18. Classification, clinicopathologic features and treatment of gastric neuroendocrine tumors.
Li TT; Qiu F; Qian ZR; Wan J; Qi XK; Wu BY
World J Gastroenterol; 2014 Jan; 20(1):118-25. PubMed ID: 24415864
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
